Gating on CLL B cells also confirmed that forodesine and dG treatment resulted in their selective loss in the SAMHD1-mutated group, while there was no effect on the same cell population in the SAMHD1 non-mutated group (Figure 5F). The gene discussed is SAMHD1; the disease is B-cell chronic lymphocytic leukemia.